Understanding how the combined treatment of PDT and CAP affects cytokine mRNA expression levels such as IL-6 and IL-8 in SCC may help to optimize treatment protocols and improve therapeutic outcomes by balancing anti-tumor effects with potential inflammatory responses. This evidence concerns the gene IL6 and neoplasm.